Healthcare Industry News: Safety Syringe
News Release - January 30, 2007
Revolutions Medical Corporation Acquires Clear Image Acquisition CorporationMOUNT PLEASANT, S.C., Jan. 30 (HSMN NewsFeed) -- Revolutions Medical Corporation (OTC: RMCP ) announces the acquisition of all assets of Clear Image Acquisition Corporation of Lexington, MA effective January 31, 2007. Revolutions Medical (Rev Med) will now have access to a working integration of software and hardware, compatible with all standard MRI systems, that interfaces with MRI industry's standard Picture Archiving Computer System (PACS). This gives Rev Med a strong proprietary position in the marketplace.
Rev Med now has a true automatic segmentation process. Rev Med has documentary evidence of the clinical utility of this unique methodology in differentiating between specific masses and lesions. Rev Med's new software can also create 3D images of MRI scans, in color as well as gray scale, using automatic segmentation. This creates a breakthrough software tool that will be available to every Picture Archiving Computer System (PACS) throughout the world.
According to Ron Wheet, CEO Revolutions Medical Corporation: "The number of radiologists and neuroradiologists has been decreasing while the number of MRI procedures has been increasing dramatically. Rev Med's new technologies will decrease the process of manually reviewing MRI images, will reduce the time necessary to rule out any abnormalities in the normal image, will reduce possible error rates, and finally will enhance overall diagnostic confidence."
There are also new provisional patents, filed in June 2006, providing a system for and method of diagnostic coding using medical image data, increasing the efficiency of a diagnostic review of medical images, and performing a medical diagnosis. In addition, the amount of MRI procedures has been growing at 15% per year with more than 20 million procedures in 2004. This acquisition puts Rev Med, with its new technologies, providing software solutions for one of the fastest growing and largest markets in the medical industry.
About Revolutions Medical Corporation
Revolutions Medical Corporation operates in the safety-engineered medical devices (SEMDs) arena. Its products include the ReVac Safety Syringe, safety blood-drawing device and the ReVac Safety IV Catheter. The world market for SEMDs was projected to exceed $1.6 billion last year and is forecasted to maintain a 20% annual growth rate in the near term.
In the United States, the Safety Syringe market is expected to generate approximately $693 million in revenues in 2006, representing 66% of the total needles and syringes market. The Theta Report estimated the number of needles and syringes sold in the U.S. and International market combined should exceed 20 billion units in 2006.
Revolutions Medical provides software solutions and tools that are compatible with standard MRIs and standard (PACS). The software includes sorting of images, color, 3D, and automatic segmentation of images.
Forward-looking statements made in this release are made pursuant to the "safe-harbor" provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements made by Revolutions Medical Corporation are not a guarantee of future performance. This news release includes forward- looking statements, including with respect to the future level of business for the parties. These statements are necessarily subject to risk and uncertainty.
Actual results could differ materially from those projected in these forward-looking statements as a result of certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Revolutions Medical Corporation, and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain and successfully complete projects, and changes in products and competition.
Source: Revolutions Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.